Lupin pharma gets USFDA nod to market ophthalmic solution

The company said it has received the final approval for its product, a generic version of Allergan Inc's Lumigan Ophthalmic Solution, from the USFDA.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news